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SUMMARY: Pulmonary neuroendocrine (NE) cells are found as clusters called neuroepithelial bodies (NEBs) or as single cells
scattered in the respiratory epithelium. They express a variety of bioactive peptides, and they are thought to be the origin of NE
lung tumors. Proadrenomedullin N-terminal 20 peptide (PAMP) is a peptide derived from the same precursor as adrenomedullin
(AM). AM and PAMP are C-terminally amidated during their processing by a well-characterized amidating enzyme, peptidylgly-
cine alpha-amidating monooxygenase (PAM). We explored AM, PAMP, and PAM expression as markers for NE hyperplasia in
three rodent species (Fischer 344 rats, Syrian golden hamsters, and A/J mice) after a single intratracheal instillation of crystalline
silica (quartz), which was previously found to induce different reactions in the three species. Rats developed a marked silicosis,
with alveolar and bronchiolar hyperplasia and formation of peripheral lung epithelial tumors. Mice developed a moderate degree
of silicosis, but not epithelial hyperplasia or tumors. Hamsters showed dust-storage lesions, but not silicosis or tumors. NE cells
were immunolabeled for calcitonin gene-related peptide (CGRP), AM, PAMP, and PAM in serial sections of each lung. The
numbers of positive NEBs per lung area and positive cells per NEB were quantified. A marked hyperplastic reaction in the NEBs
of silica treated rats occurred only in alveolar NEBs, but not in bronchiolar NEBs. From Month 11 onwards, there were marked
differences in the number of alveolar NEBs per section and in the number of cells per alveolar NEB immunoreactive for CGRP.
No hyperplastic NE cell reaction was observed in silica-treated mice and hamsters. Significant PAMP and PAM expression was
seen only in rat hyperplastic alveolar and in bronchiolar NEBs from Month 11 onwards. In E18, rat fetal lung NEBs were found
to be strongly positive for PAMP and PAM. (Lab Invest 2001, 81:1627–1638).
T he diffuse neuroendocrine (NE) system of thelung is represented in the bronchopulmonary
tract by two different elements: solitary pulmonary
neuroendocrine cells (PNECs) and clustered neuroen-
docrine cells, called neuroepithelial bodies (NEBs),
which are usually innervated structures (Van Lommel
and Lauweryns, 1997).
NE cells of the lung express and secrete several
peptides: calcitonin gene-related peptide (CGRP),
bombesin or gastrin-releasing peptide (GRP), and
calcitonin (CT). Several other immunohistochemical
markers label these cells: neuron-specific enolase,
chromogranin, PGP 9.5, serotonin, etc. (Scheuer-
mann, 1997). There is a considerable interspecies
variation in the pattern of peptides expressed by
pulmonary NE cells, but in the three species that we
studied (rat, hamster, and mouse) CGRP is the most
abundant peptide (Van Lommel et al, 1995) and can be
used as a general marker for the endocrine population
of the lung.
The roles and possible interplay of pulmonary NE
cells in normal lung physiology are not completely
clear, but current indications are that NEBs and
PNECs act as intrapulmonary chemoreceptors sensi-
tive to hypoxia and hypercapnia and may also exert a
paracrine control on the proliferative activity of neigh-
boring cells (Gould et al, 1983; McDowell et al, 1994;
Sorokin et al, 1997). A variety of peptides with several
proposed biological functions, such as bombesin and
CGRP, are produced and secreted by pulmonary NE
cells (Van Lommel et al, 1999). Several studies have
provided strong support for the relationship between
pulmonary NE cells and intrauterine and postnatal
pulmonary growth and maturation (Emanuel et al,
1999; Sorokin et al, 1997). Some peptides produced
and secreted by the respiratory NE cells strongly
stimulate proliferation of lung epithelial cells in vitro
(Cuttitta et al, 1985). The relevance of NE cells in
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airway repair after acute lung injury has been studied
in several models (Nylen and Becker, 1993). Recent
data support the hypothesis that the NEB microenvi-
ronment is critical for the maintenance of a “reserve”
stem cell population that participates in airway repair
upon injury (Reynolds et al, 2000a).
NE hyperplasia has been observed in different
mammalian species in relation to a variety of lung
conditions or experimental treatments in which regen-
eration of the chronically injured airways or alveoli is
triggered. Either the total number of NEBs, the cell
density of each NEB, or both are increased in lung
inflammatory, fibrotic, or dysplastic conditions
(Aguayo et al, 1990; Willett et al, 1999) or after the
exposure to some toxic or carcinogenic products like
nicotine or cigarette smoke (Aguayo, 1993), N-nitroso
compounds (Huntrakoon et al, 1989; Sunday and
Willett, 1992), or asbestos (Johnson et al, 1980; Shep-
pard et al, 1982). Cigarette smokers with NE hyper-
plasia have a greater risk of developing smoking-
related lung disease than smokers without NE
hyperplasia (Aguayo, 1993).
Some histological types of human lung tumors show
neuroendocrine differentiation: carcinoids, small cell
lung cancer, and large cell neuroendocrine carcinoma.
These tumor cells express common neuroendocrine
markers and share ultrastructural features with normal
lung NE cells (Gould et al, 1983; Mosca et al, 1988).
PNEC hyperplasia has been proposed as a preneo-
plastic lesion leading to these neuroendocrine lung
tumors (Gould et al, 1983).
NE cell hyperplasia could derive either from prolif-
eration of differentiated NE cells or from the recruit-
ment of nondifferentiated “stem” cells to the endo-
crine differentiation pathway (Willett et al, 1999).
Markers for proliferation have been found in differen-
tiated endocrine cells (Montuenga et al, 1992b;
Stevens et al, 1997), but the participation of non-NE
progenitor cells in the process has also been shown
(Reynolds et al, 2000a, 2000b). Changes in the intra-
cellular levels of peptides that render the cells more
detectable by immunocytochemical techniques have
also been proposed to explain the rapid increase of
endocrine cell numbers found in acute conditions
(Bousbaa et al, 1994).
We studied the endocrine cell dynamics in animal
models based on a single intratracheal instillation of
crystalline silica (quartz) in three species (rats, ham-
sters, and mice) that markedly differ for their response
to silica (Saffiotti et al, 1996). In F344 rats, silica
produces a progressive chronic inflammatory and
fibrogenic reaction (silicotic lesion), accompanied by
hyperplasia of alveolar epithelial type II cells, with the
formation of adenomatoid proliferations and, eventu-
ally, of peripheral epithelial tumors of different types,
mostly adenocarcinomas and adenomas, but also
some squamous cell carcinomas, undifferentiated
large cell carcinomas, and mixed-type carcinomas. No
small cell or other neuroendocrine-like carcinomas
were induced in the time frame of the experiment (up
to 24 months). Mice of the A/J, BALB/c, and NCr/Nu
(athymic nude) strains developed silicotic nodules with
necrotic centers, but not persistent alveolar epithelial
hyperplasia or lung carcinomas. In Syrian golden
hamsters, crystalline silica elicited only a macrophagic
storage reaction, and not fibrosis, epithelial reactions,
or tumors (Saffiotti, 1993; Saffiotti et al, 1996).
The present study was also aimed at finding possi-
ble markers for reactive-hyperplastic NE cells. So far,
studies reporting changes in the numbers of NE cells
in the lung under various experimental conditions have
used general neuroendocrine markers or CGRP/calci-
tonin. In a proinflammatory environment such as the
silicotic lung, extracellular signaling leads to the induc-
tion or repression of a variety of genes in the endo-
crine cells that may become eventually hyperplastic.
Other conditions, such as hypoxia, may also affect the
pattern of gene expression in these cells. In the
present study, we assessed the expression of
proadrenomedullin-derived peptides during the
silicotic-carcinogenic process. Proadrenomedullin-
derived peptides are induced by proinflammatory cy-
tokines (Takahashi et al, 2000) and hypoxia (Garayoa
et al, 2000) both in vitro and in vivo. We also studied a
new general neuroendocrine marker, the C-terminally
amidating enzyme of peptides, peptidylglycine alpha-
amidating monooxygenase (PAM), which may also be
regulated by cytokines (Scott et al, 1996).
Adrenomedullin (AM) is a peptide with different
biological functions (Hinson et al, 2000; Kitamura et al,
1993). Pulmonary AM expression has been previously
described in several cell types: bronchiolar epithelium,
smooth muscle of both blood vessels and bronchi-
oles, chondrocytes, and alveolar macrophages (Kubo
et al, 1998; Martinez et al, 1995). Some nonsmall cell
lung carcinomas show increased expression of this
peptide (Martinez et al, 1995). Several endocrine cells
and organs also express AM. Proadrenomedullin
N-terminal 20 peptide (PAMP) is a second peptide
derived from the same precursor as AM (Kitamura et
al, 1994). Both of these are amidated peptides and
PAM is involved during their processing. PAM is the
only C-terminal amidating enzyme found in mammals
thus far (Prigge et al, 1997); however, it is found in a
variety of lung tumors (Saldise et al, 1996) and has
been proposed as a candidate for therapeutic inter-
vention leading to autocrine growth factor inhibition in
cancer (Iwai et al, 1999). PAMP and PAM can be used
as NE markers because PAMP expression is related to
endocrine cells in different organs, and PAM takes
part in the processing of different peptides, including
PAMP, by amidation of the C-terminal end.
Results
Table 1 summarizes the immunohistochemical find-
ings. Table 2 reports the quantitative data obtained
with CGRP in treated and control rats.
Fetal Rat Lung
E18 Rat fetal lungs showed a large number of NEBs
per section, which were strongly positive for CGRP.
Most NEBs were located in the bronchioles. Using
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serial reverse-face sections, we could determine that
the same NE cells were also immunoreactive for
PAMP and for PAM, but not for AM. Immunostaining
was predominantly concentrated at the basal side of
the clustered endocrine cells (Fig. 1). No isolated
PNEC was immunostained with the antibodies used.
NEBs and PNECs in Normal Adult Rat Lung
NE cells were present in adult rat lungs as clustered
alveolar and bronchiolar NEBs or as isolated bron-
chiolar PNECs. AM was expressed in isolated PNECs,
but not in NEBs. In the present study the nonendo-
crine bronchiolar cells were not immunostained for AM
except when the antibody was used in superoptimal
concentrations.
NEBs in rats instilled with saline showed the same
pattern of peptide expression as untreated adult rats,
being positive for CGRP and negative for AM, PAMP,
and PAM. These NEBs were not hyperplastic. Saline-
instilled rats and untreated rats had similar numbers of
alveolar and bronchiolar NEBs per unit area and of
cells per alveolar and bronchiolar NEBs (Table 2).
No significant differences were found between the
lungs of untreated young rats (8 weeks old) and
untreated aged rats (18 months). The expression
pattern of the tested peptides did not change with the
age of the rats.
NEB and PNEC Hyperplasia in Rat Lungs after
Silica Instillation
Using CGRP immunostaining as general marker, a
statistically significant NEB hyperplasia was observed
for the first time at Month 11 after silica treatment and
was found to progress at later experimental times (Fig.
2, Table 2). Most of the hyperplastic NEBs were
located in the alveoli.
In rats killed 17 or more months after treatment,
significant differences were found in the number of
NEBs per section and in the average number of cells
per alveolar NEB, but no significant differences were
found in the number of cells per bronchiolar NEB (Fig.
2). Approximately one half of the hyperplastic NEBs
were adjacent to areas of nonendocrine epithelial cell
hyperplasia.
AM, PAMP, and PAM in Hyperplastic NE Cells
The patterns of expression of proadrenomedullin-
derived peptides and of the amidating enzyme were
studied (Table 1). During the first 5 months after silica
instillation, there was no detectable expression of
PAMP and PAM in the NE cells. In rats killed at 11
months or later, most of the NE cells were immuno-
stained for both PAM and PAMP (Fig. 3). The levels of
expression of both markers increased with experimen-
tal time. There were also differences in the staining
intensity among endocrine cells present in the same
NEB at a given point; even after long observation
times, there was always a subpopulation of CGRP-
positive cells that apparently were not expressing
either of the other two markers. NE cells within hyper-
plastic NEBs were consistently negative for AM immu-
nostaining. The specificity of the immunostaining for
AM, PAMP, CGRP, and PAM was confirmed by neg-
ative results obtained with blocked antibodies.
Significant differences were found in the expression
of PAMP and PAM in the silica-treated lungs com-
pared with age-matched untreated rats, both for the
number of alveolar NEBs and the number of cells per
alveolar NEBs (p  0.05 and  0.05, respectively for
PAM, and p  0.01 and  0.01, respectively for
PAMP). No significant differences were found in the
number of bronchiolar NEBs and the number of cells
per bronchiolar NEB (Fig. 2).
The NEBs of treated and untreated rats were con-
sistently negative for AM, whereas isolated PNECs
present in the bronchiolar epithelium of all groups
were immunoreactive with the specific antibody
against AM (Fig. 4). PNECs were always negative for
CGRP, PAMP, and PAM.
Table 1. Distribution of Peptide Expression in Lung
Endocrine Cells of Fetal, Normal, and Silica-Treated
Rats, Mice, and Hamsters
Alveolar
NEB
Bronchiolar
PNEC NEB
CGRP CGRP
Fetal rat Nd PAMP PAMP
PAM PAM
AM AM
Normal adult CGRP CGRP CGRP
rat PAMP PAMP PAMP
PAM PAM PAM
AM AM AM
Silica rat CGRP CGRP CGRP
0–5 mo PAMP PAMP PAMP
PAM PAM PAM
AM AM AM
Silica rat CGRP CGRP CGRP
11–24 mo PAMPa PAMP PAMPa
PAMb PAM PAMb
AM AM AM
Silica-treated CGRP
mouse Nd Nd PAMP
PAM
AM
Silica-treated CGRP
hamster Nd Nd PAMP
PAM
AM
Nd, not determined; NEB, neuroepithelial body; PNEC, pulmonary neuroen-
docrine cells (isolated); CGRP, calcitonin gene-related peptide; PAMP, proad-
renomedullin N-terminal 20 peptide; PAM, peptidylglycine alpha-amidating
monooxygenase; AM, adrenomedullin.
a Some NEBs are negative. Some cells of positive NEBs are negative.
b Some cells are negative.
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The hyperplastic alveolar and bronchiolar NE cell
populations were compared both in terms of NEB
number and the number of cells per NEB by applying
a Wilcoxon test. Using CGRP as a general NEB
marker, very significant differences were found be-
tween the two regions (alveolar vs bronchiolar) in the
NEB number (p  0.01) and in the number of cells per
NEB (p  0.01). Similar results were found using PAM
(p  0.01 and p  0.01, respectively) and PAMP (p 
0.01 and p  0.01, respectively) as NE markers.
Proliferative Status of Differentiated Endocrine Cells in
the Hyperplastic Lesions
The cellular proliferation that leads to NEB hyperplasia
was studied using reverse-face sections immuno-
stained respectively for CGRP and proliferating cell
nuclear antigen (PCNA). A very low number of CGRP-
positive cells (less than one or two per NEB) were
found to be also positive for PCNA immunostaining.
Some PCNA-positive cells were observed to be adja-
cent to (or in proximity of) CGRP-positive neuroendo-
crine cells (Fig. 5).
Endocrine Cells in Mouse and Hamster Lungs after
Silica Instillation
In the lungs of mice and hamsters, using CGRP as
general marker, no significant variations were ob-
served in the number of NEBs throughout the exper-
iment and in the number of cells per NEB. In the
mouse and hamster, NEBs were immunoreactive for
PAM, but not for PAMP at all time points. NEBs were
detected in hamster with antibodies against PAM, but
not against PAMP at all time points. Some hamster
bronchiolar NEBs were also positive for AM, in con-
trast to mice and rats (Fig. 6).
Isolated bronchiolar PNECs have been previously
described in hamster and mouse lungs (Ito et al, 1998;
Stevens et al, 1997), but no immunoreactivity was
observed in PNEC with our reagents for any of the
markers presently studied, including CGRP.
Discussion
The present results demonstrate that NEB hyperplasia
is present in rat lungs after intratracheal instillation of
crystalline silica. Previous studies reported pulmonary
PNEC and NEB hyperplasia in several experimental
conditions in which the lung epithelial cells are ex-
posed to inflammatory cytokines, chronic hypoxia, or
a variety of toxic compounds. Interestingly, several
groups (Johnson et al, 1980; Sheppard et al, 1982)
reported that asbestos inhalation produces NE hyper-
plasia in rats. After quartz instillation in the present
model, a very significant hyperplasia of NE cells was
found in rat lungs, but it did not occur in mice and
hamsters that underwent the same treatment. Carci-
nogenesis in rat lungs by silica has a long latent
period, and tumors were formed in rats killed at 11
months or later. The increase of NE cells is not due to
the age of the rats, because untreated old rats did not
show NE hyperplasia. The observed species differ-
ence in NE cell reaction parallels the reported species
differences in silica-induced lung carcinogenesis. In
the rat, intratracheal silica induces extensive progres-
sive silicosis, peripheral epithelial hyperplasia, and a
marked carcinogenic response, whereas neither ham-
sters nor mice develop lung carcinomas (Saffiotti,
1993; Saffiotti et al, 1996). The mechanisms respon-
sible for the striking differences in susceptibility to
silica-induced carcinogenesis remain to be eluci-
dated, but the role of cellular mediators that may affect
Table 2. Number of NEBs per Section and Average Number of Cells per NEB in Control and Silica-Treated Rats Killed at
Different Timesa
Time
Alveolar Bronchiolar
NEB/cm2 Cells/NEB NEB/cm2 Cells/NEB
Fetal rat 29.131 2.37 5.25 0.42
Aged ratsb 3.68 2.28 6.37 4.08 6.21 3.32 6.69 2.87
Saline instilledc 2.13 2.84 2.44 2.36 3.01 3.25 2.44 2.69
Controld 4.05 4.32 2.59 2.36 2.61 2.47 1.96 1.31
1 mo 3.97 1.98 8.1 2.78 4.81 2.24 8.7 3.69
2 mo 1.72 1.79 3.51 3.25 1.16 0.76 4.42 4.24
3 mo 1.13 0.15 2.5 0.36 3.38 0.12 3.66 0.14
4 mo 1.95 1.3 5.27 3.55 1.54 0.75 6.05 1.3
5 mo 1.95 0.22 5.71 1.53 2.91 0.23 5.16 2.11
11 mo 11.7 0.47 9.84 2.61 4.7 1.37 3.47 0.81
17 mo 13.9 4.92* 34.6 9.17* 1.95 1.12 9.64 6.33
23 mo 23.9 6.76* 32.8 7.60* 4.21 0.60 8.25 1.37
a Both the number of alveolar NEBs per section and the average number of cells per alveolar NEB, increase significantly with time. Based on CGRP immunostaining.
b Aged rats, untreated rats, ages 19 to 28 months (n  34).
c Saline instilled, 8-week-old rats instilled with saline only and killed at different time points: 1 month (n  2), 2 months (n  10), 4 months (n  2), 6 months
(n  4).
d Control, untreated 8-week-old rats (n  15).
* p  0.01. p values were calculated using a Kruskal Wallis test and U-Mann Whitney as post hoc test, comparing each time point with time 0. Bonferroni
adjustment was applied.
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alveolar cell proliferation has been considered (Saf-
fiotti, 1993; Seiler et al, 2001). The NE cell hyperplasia
in the rat—the species of choice for silica carcinogen-
esis—and its possible role in stimulating cell prolifer-
ation in the adjacent epithelia represents a further
hypothetical mechanism. These species differences
may be related to other differences in the inflammatory
cell response to silica (Driscoll et al, 1996; Schim-
melpfeng and Seidel, 1991) and to the role of growth
factors such as TGF- and TNF- (Saffiotti, 1993;
Williams et al, 1996).
In normal rats, bronchiolar and alveolar NEBs are
morphologically indistinguishable, and they produce a
similar set of peptides. Nevertheless, the observed
response of NEBs to silica varies with their localization
within the lung. Our quantification protocol shows that
two types of NEBs can be distinguished according to
their localization, ie, bronchiolar and alveolar. The
existence of two subpopulations of NE cells, with
different biological properties, had already been sug-
gested for rat lung (Tsutsumi, 1989). Bearing in mind
this diversity, we studied separately the response to
silica instillation of both subpopulations of NEBs. Only
alveolar NEBs react to silica by producing NE hyper-
plasias. In contrast, no significant differences were
seen in the number of bronchiolar NEBs per lung
section nor in the number of cells per bronchiolar NEB.
Huntrakoon et al (1989) demonstrated that rabbits,
injected subcutaneously with diethylnitrosamine
(DEN), developed NEB hyperplasia, and most of those
NEBs were localized in the alveolar region. In ham-
sters, DEN injections caused NEB hyperplasia located
in bronchioles (Linnoila et al, 1984). In the present rat
model, the intratracheally instilled silica particles were
concentrated in the peripheral regions of the lung and
were found to cause more serious damage to these
regions than to the more proximal airways. In fact,
intratracheal instillation of crystalline silica in rats pro-
vides an animal model for the study of peripheral lung
carcinogenesis, in which bronchial tumors were not
observed. In addition, bronchiolar and alveolar NE
cells may have different biological behavior and sen-
sitivity to certain toxic effects.
Recent literature has paid attention to the question
of whether differentiated NE cells are capable of
proliferation, and whether hyperplastic reactions are
due to neuroendocrine cell division or to the recruit-
ment and differentiation of nearby epithelial stem cells
(Reynolds et al, 2000a, 2000b). In the present model,
serial PCNA/endocrine marker immunohistochemical
Figure 1.
E18 Rat fetal bronchiolar neuroepithelial bodies (NEBs) marked with different peptides. A, B, and D are perfectly consecutive sections showing the same group of
cells (arrows) immunostained for calcitonin gene-related peptide (CGRP) (A), proadrenomedullin N-terminal 20 peptide (PAMP) (B), and adrenomedullin (AM) (D).
C, A fetal bronchiolar NEB immunostained for peptidylglycine alpha-amidating monooxygenase (PAM). Magnification, 1250.
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studies were performed to address this question. We
found low, but consistent, levels of colocalization of
PCNA and CGRP at the time points when the numbers
of endocrine cells were sharply increasing. Nonendo-
crine PCNA-positive epithelial cells were also found in
close contact to the NE cells in the alveolar NEBs.
Previous studies have shown that the levels of prolif-
eration of lung endocrine cells are very low, although
some endocrine cell division may occur (Montuenga et
al, 1992a). It has also been shown that nonendocrine
cells proliferate in close proximity to the NE cells,
suggesting stem cell renewal before endocrine differ-
entiation. It has been recently proposed that NE cells
function as a self-renewing progenitor population and
that NEB-associated Clara cells are not necessary for
NE cell hyperplasia (Reynolds et al, 2000a, 2000b).
Although quantification is difficult because of the low
number of cells that are double-stained by PCNA and
peptides, the present results suggest a mixed model
in which NE cell hyperplasia is caused by both endo-
crine and nonendocrine cell proliferation.
Neuroendocrine cells of the lung produce and se-
crete a variety of bioactive peptides. So far, none of
the peptides reported has been found to be specific
for hyperplastic cells. The well-established markers for
neuroendocrine cells, such as chromogranin A (Ferrari
et al, 1999), neuron-specific enolase (Mosca et al,
1988), bombesin (Emanuel et al, 1999) or, in the case
of rodents, CGRP (Johnson et al, 1988), have been
used to detect both normal or hyperplastic NE cells.
For the first time, the present study found that PAMP,
a peptide derived from the same precursor of AM
Figure 2.
Change in the number of NEBs in the lungs of silica-instilled rats, studied using CGRP, PAMP, and PAM as neuroendocrine markers. The number of alveolar NEBs
and the number of neuroendocrine (NE) cells per alveolar NEB increase significantly after long treatment periods (11–17 months). The number of bronchiolar NEBs
and the number of cells per bronchiolar NEB do not change significantly. Very significant differences are found with each marker, when bronchiolar and alveolar data
are compared *p  0.05, **p  0.01.
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(Samson, 1998), is expressed at considerably higher
levels in hyperplastic endocrine cells than in the cells
of normal NEBs and thus could be used as a marker
for reactive NE cells, at least in rats. Hyperplastic
NEBs of silica-treated rats after the 11th month show
PAMP immunoreactivity. Expression of PAMP was
also high during the last stages of lung morphogene-
sis, when the neuroendocrine cells are known to be
particularly abundant and functionally relevant (Mc-
Dowell et al, 1994). NEBs of untreated adult rats are
virtually negative for immunoreaction against PAMP. A
similar temporal pattern of expression was found for
the C-terminal amidating enzyme PAM, which is re-
quired for the posttranslational processing of
C-terminally amidating peptides like AM or PAMP. We
confirmed that this differential expression of PAMP
and PAM is due to the treatment, not to the age, of
rats. These data collectively suggest that PAMP and
PAM overexpression are good markers for activated
neuroendocrine cells like those present in embryogen-
esis and in reactive conditions like the hyperplasia
observed in the rat silicotic model. Up-regulation of
preproadrenomedullin gene expression by lipopoly-
saccharide (Zaks-Zilberman et al, 1998), a variety of
inflammatory cytokines (Takahashi et al, 2000), and
hypoxia (Garayoa et al, 2000) has already been re-
ported. The levels of inflammatory cytokines are sig-
nificantly increased in silicotic lung lesions (Barrett et
al, 1999; Driscoll et al, 1996; Orfila et al, 1998; Roja-
nasakul et al, 1999). In later stages of human silicosis,
Figure 3.
Serial face-reverse consecutive sections of a hyperplastic alveolar NEB (asterisks) of a silica treated rat at 17 months. A, CGRP immunostaining labels the endocrine
cells of the hyperplastic NEB. These hyperplastic cells are also positive for PAMP (B) and PAM (C). D, Immunostaining for AM is negative. Magnification, 500.
Figure 4.
Bronchiolar epithelium of a silica-treated rat at 17 months showing several
pulmonary neuroendocrine cells (PNECs) immunostained for AM (arrow-
heads). Smooth muscle is also positive. Magnification, 1250.
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hypoxia is also present (Wang and Yano, 1999) and, in
the rat model, edema, alveolar proteinosis, and fibro-
sis would lead to hypoxia. This chronic hypoxia may
also explain the increased expression of PAMP found
in the reactive NEBs.
We report here for the first time that the isolated
PNECs of the bronchiolar epithelium are immunoreac-
tive for AM, the other peptide derived from the same
precursor as PAMP. There was an increase in the
number of PNECs in the early stage of the silicotic
process in rats. Previous animal models of NEB hy-
perplasia, such as DEN treatment in rabbits (Huntra-
koon et al, 1989), did not show any apparent variation
in the number of PNECs. Martinez et al (1995) previ-
ously reported immunoreactivity for AM in normal
human, nonendocrine bronchiolar epithelial cells. In
the present study, the nonendocrine rat bronchiolar
cells were not immunostained except when the anti-
body was used in superoptimal concentrations. The
reagent used in the present study on rat samples is
not the same that was used in the previous study on
human tissues, although it was raised against exactly
the same epitope. In the present work, we have also
shown that bronchiolar PNECs expressed only AM
and did not seem to produce PAMP or PAM. In
contrast, hyperplastic and embryonic NEBs accumu-
late PAMP and PAM, but not AM (Table 1). These
results clearly support the earlier suggestions (Van
Lommel et al, 1999) that PNECs and NEBs are biolog-
ically different entities with distinct physiological prop-
erties and probably different functional roles.
In summary, a single intratracheal instillation of
crystalline silica caused alveolar NEB hyperplasia in
rats, but not in hamsters or mice. Two subpopulations
of NE cells (bronchiolar and alveolar) were distin-
guished in relation to their expression of regulatory
peptides and their response to silica. Pulmonary neu-
roendocrine cells showed cell type-specific expres-
sion of both proadrenomedullin-derived peptides, AM
and PAMP, and of the amidating enzyme, PAM. Fi-
nally, the expression of these peptides in rat NEBs
changed with time after treatment, and hyperplastic
NEBs, observed at late stages after silica treatment,
showed the same expression pattern as embryonic
NEBs, suggesting that PAMP and PAM may be good
markers for reactive neuroendocrine cells. The ques-
tion remains open whether the activation of NE cells
by crystalline silica in the peripheral lung epithelium in
rats is involved in the complex mechanisms of carci-
nogenesis at that target site.
Materials and Methods
Paraffin-embedded tissues from adult rats, hamsters,
and mice were obtained from previous experiments
carried out at the National Cancer Institute (NCI),
Bethesda, Maryland (Saffiotti, 1993; Saffiotti et al,
1996). Tissues from fetal rats came from new experi-
ments carried out at the University of Navarra, Na-
varra, Spain. All immunohistochemical studies and
their quantitation were performed at the University of
Navarra. New experiments of silica instillation are
under way at the University of Navarra, and the earlier
time points (12 months) gave similar results to the
ones obtained with the NCI archival material.
Rats
Fischer F344/NCr female rats from the Animal Produc-
tion Branch, NCI/Frederick Cancer Research Facility
(Frederick, Maryland) were used. The crystalline silica
sample was 99% pure -quartz (min-U-Sil 5, Pennsyl-
vania Glass Sand Co., Pittsburgh, Pennsylvania), with
particle size 5 m (Saffiotti, 1993). Just before
instillation, it was autoclaved, resuspended in neutral
buffered saline, and briefly sonicated to provide full
dispersion. Rats at 8 weeks of age were anesthetized
with a mixture of oxygen and methoxyflurane, then
were placed on their backs on a metal board slanted
at a 60° angle with the mouth kept open, and in this
position, at the end of an expiration, they received a
single intratracheal instillation of 12 mg quartz in 0.3
ml saline through a 7-cm-long, 19-gauge stainless
steel blunt cannula, bent at a 140° angle near the top,
connected to a syringe.
The rats were housed in specific-pathogen-free
conditions with access to food and water ad libitum.
The rats were killed after different time periods since
Figure 5.
Proliferative status of NE cells in NEBs. Serial reverse-faced sections showing
a hyperplastic alveolar NEB of a silica-treated rat at 17 months immunostained
for CGRP (A) and proliferating cell nuclear antigen (PCNA) (B). Only some NE
cells are positive for PCNA (thick arrows). A very low number of adjacent NE
cells (thin arrows) is also positive for PCNA. Magnification, 1250.
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the instillation, between Day 0 and two years. The
tissues used in the present study were obtained from
killings at Months 1 (n  9), 2 (n  8), 3 (n  2), 4 (n 
4), 5 (n  3), 11 (n  2), 17 (n  15), and 23 (n  5).
The rats were killed by exsanguination under anes-
thesia. The trachea was exposed by dissection and
ligated during maximal inspiration. The larynx, tra-
chea, bronchi, lungs, lymph nodes, and heart were
removed en bloc and fixed by immersion in 4%
formaldehyde in a 300-milliosmolar phosphate buffer
for 24 hours. Lung lobes were sectioned along their
main bronchial axis, embedded in paraffin, and sec-
tioned at 4-m thickness.
Three different groups of control rats were included
in the study. A group of untreated 8-week-old rats
were considered as the 0 time point of treatment (n 
15). Untreated rats, aged from 19 to 28 months, were
included as controls for the aged groups (n  34). A
group of 8-week-old rats was instilled with saline only
and killed at the following time points: 1 month (n 2),
Figure 6.
Bronchiolar NEBs of mouse and hamster immunostained for different peptides. A, Murine NEB immunostained for CGRP. B, Bronchiolar NEB of a hamster
immunostained for CGRP. C, Murine bronchiolar NEB immunostained for PAM. D, PAM immunostaining of a hamster NEB. E, AM immunostaining of a hamster NEB.
Magnification, 1250.
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2 months (n  10), 4 months (n  2), and 6 months
(n  4).
Rat Fetuses
Rat fetuses, obtained from F344/NHsd dames at the
18th day of gestation, were studied. Their lungs were
removed and fixed in 4% formaldehyde or Bouin’s
fluid for 17 hours. They were sectioned along their
main bronchial axis, embedded in paraffin, and sec-
tioned at 4-m thickness.
Mice and Hamsters
The lungs of 12 A/JCr mice and 16 Syrian golden
hamsters were used. The quartz dose was 10 mg in
0.1 ml saline for mice, and 20 mg in 0.3 ml saline for
hamsters. Mice and hamsters were instilled using the
methods described for rats, with minor modifications,
and their lung tissues were processed in the same
way. The lung sections used for the present study
came from mice killed at Day 3 and at Months 1, 3,
and 6, and from hamsters killed at Day 3 and at
Months 1, 3, 6, and 12 (n  3 in each time point).
Immunohistochemistry
A specific polyclonal antiserum anti-CGRP (RPN1842;
Amersham, Barcelona, Spain) was used as a general
marker for NE cells of the lung at a dilution 1:5000. For
the study of AM and PAMP, two polyclonal antisera
obtained in rabbit were employed (2469-anti P072 and
2337-anti P070) (Jimenez et al, 1999; Martinez et al,
1995) at a dilution of 1:3000 and 1:1000, respectively.
PAM was detected using a mouse monoclonal anti-
body (2573, clone G8) (Jimenez et al, 2001), diluted
1:2000. The experiments with PCNA were carried out
using a commercial monoclonal antibody (MO879,
PC10 clone; Dako, Barcelona, Spain), at a dilution of
1:200. Analyses of colocalization of different peptides
or markers in the same NEBs were carried out in serial
reverse-face sections.
For the immunohistochemical technique, the EnVi-
sion (K4011 and K4007; Dako, Barcelona, Spain)
signal enhancement system was used. Slides were
deparaffined and their peroxidase blocked with 3%
H2O2 in water. Tissues were incubated with 5% nor-
mal goat serum in TBS (Tris-HCl 0.05M, 0.5M ClNa,
pH  7.36) for 30 minutes at room temperature. After
blotting the excess serum from the sections, the
diluted primary antiserum was applied and left over-
night at 4° C. Tissues were washed in TBS and incu-
bated with the secondary monoclonal or polyclonal
EnVision complex for 30 minutes at room tempera-
ture. After washing the slides in TBS, development of
peroxidase with diaminobenzidine and H2O2 was per-
formed. Tissues were contrasted with Harris hematox-
ylin and mounted with distyrene, plasticizer, xylene
(DPX) mounting medium (BDH, Poole, England). The
Histomouse-SP blocking system (95–9541; Zymed
Laboratories Inc., San Francisco, California) was em-
ployed when mouse monoclonal antibodies were used
on mouse lung.
Blocking controls were performed for the peptides
we studied. The antibody was preincubated with the
peptide overnight at 4° C. The immunohistochemistry
was carried out using the blocked antibody.
Quantitative Studies
Sections from each block were immunostained for
CGRP, AM, PAMP, and PAM. NEBs were classified in
two types according to their localization within the
lung. “Bronchiolar” NEBs were those which were
surrounded by bronchiolar epithelium; “alveolar”
NEBs were those found in contact with alveolar epi-
thelium. The number of positive alveolar NEBs and
bronchiolar NEBs in each section after immunostain-
ing with each of the markers was counted. The num-
ber of positive cells per NEB was also counted in each
case. Only those cells with a visible nucleus were
counted. These values were divided by the total area
of each lung section, to correct for the probability of
finding a NEB per unit area of the section. To get the
total sectioned area, the slides were scanned with a
Duoscan T1200 AGFA scanner (Madrid, Spain) and
the number of square centimeters corresponding to
lung tissue (excluding major blood vessels and bron-
chi) was measured with the help of an image analysis
program (Scion; NIH, Bethesda, Maryland). The aver-
age NEB frequency was calculated for each experi-
mental group. Proliferative status of the cells was
examined by immunostaining with PCNA.
Statistics
The results were statistically analyzed with the SPSS
9.0 program (SPSS Inc., Chicago, Illinois). A Kruskall
Wallis test was applied, because not all of the groups
had more than 10 individuals. In those cases in which
statistical variations were seen, different time points
were compared with the corresponding control group
using a U-Mann Whitney test with the Bonferroni
adjustment. Paired comparisons for alveolar and
bronchiolar NEBs were performed using a Wilcoxon
test (Chan and Walmsley, 1997).
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